2-Aminoindane: Difference between revisions

Line 7:

==Pharmacology==

Due to the lack of research regarding the substance, all discussion regarding the pharmacology of it is purely based upon its structure and subjective effect similarities to other [[stimulant]]s such as [[amphetamine]], [[methamphetamine]] and [[2-FMA]]. 2-AI most likely acts as both a [[dopamine]] and [[norepinephrine]] [[~~reuptake inhibitor~~]]. This means it effectively boosts the levels of the norepinephrine and dopamine neurotransmitters in the brain by binding to and partially blocking the transporter proteins that normally remove those monoamines from the synaptic cleft. This allows dopamine and norepinephrine to accumulate within the brain, resulting in [[stimulation|stimulating]] and [[physical euphoria|euphoric]] effects.

Due to the lack of research regarding the substance, all discussion regarding the pharmacology of it is purely based upon its structure and subjective effect similarities to other [[stimulant]]s such as [[amphetamine]], [[methamphetamine]] and [[2-FMA]]. 2-AI most likely acts as both a [[dopamine]] and [[norepinephrine]] [[releasing agent]]. This means it effectively boosts the levels of the norepinephrine and dopamine neurotransmitters in the brain by binding to and partially blocking the transporter proteins that normally remove those monoamines from the synaptic cleft. This allows dopamine and norepinephrine to accumulate within the brain, resulting in [[stimulation|stimulating]] and [[physical euphoria|euphoric]] effects.

==Subjective effects==

@@ Line 7: / Line 7: @@
 ==Pharmacology==
-Due to the lack of research regarding the substance, all discussion regarding the pharmacology of it is purely based upon its structure and subjective effect similarities to other [[stimulant]]s such as [[amphetamine]], [[methamphetamine]] and [[2-FMA]]. 2-AI most likely acts as both a [[dopamine]] and [[norepinephrine]] [[reuptake inhibitor]]. This means it effectively boosts the levels of the norepinephrine and dopamine neurotransmitters in the brain by binding to and partially blocking the transporter proteins that normally remove those monoamines from the synaptic cleft. This allows dopamine and norepinephrine to accumulate within the brain, resulting in [[stimulation|stimulating]] and [[physical euphoria|euphoric]] effects.
+Due to the lack of research regarding the substance, all discussion regarding the pharmacology of it is purely based upon its structure and subjective effect similarities to other [[stimulant]]s such as [[amphetamine]], [[methamphetamine]] and [[2-FMA]]. 2-AI most likely acts as both a [[dopamine]] and [[norepinephrine]] [[releasing agent]]. This means it effectively boosts the levels of the norepinephrine and dopamine neurotransmitters in the brain by binding to and partially blocking the transporter proteins that normally remove those monoamines from the synaptic cleft. This allows dopamine and norepinephrine to accumulate within the brain, resulting in [[stimulation|stimulating]] and [[physical euphoria|euphoric]] effects.
 ==Subjective effects==